Shandong Wohua Pharmaceutical Co Ltd (002107) — Cash Flow-to-Debt Ratio
Shandong Wohua Pharmaceutical Co Ltd (002107) has a Cash Flow-to-Debt Ratio of 0.08x as of December 2025, meaning its operating cash flow of CN¥19.82 Million could theoretically repay 0% of its total liabilities (CN¥244.73 Million) in one year. See 002107 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shandong Wohua Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2003–2025)
Historical debt coverage capacity for Shandong Wohua Pharmaceutical Co Ltd across 23 annual periods. For the full cash flow conversion analysis, see Shandong Wohua Pharmaceutical Co Ltd operating cash flow efficiency.
Annual Cash Flow-to-Debt Ratio for Shandong Wohua Pharmaceutical Co Ltd (2003–2025)
Year-by-year debt coverage analysis for Shandong Wohua Pharmaceutical Co Ltd. Check how high is Shandong Wohua Pharmaceutical Co Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.53x | CN¥128.53 Million | CN¥244.73 Million | ▲ +50.8% |
| 2024 | 0.35x | CN¥91.51 Million | CN¥262.80 Million | ▼ -16.1% |
| 2023 | 0.42x | CN¥129.25 Million | CN¥311.23 Million | ▼ -30.5% |
| 2022 | 0.60x | CN¥185.26 Million | CN¥310.20 Million | ▼ -30.8% |
| 2021 | 0.86x | CN¥200.12 Million | CN¥231.83 Million | ▲ +98.5% |
| 2020 | 0.43x | CN¥196.58 Million | CN¥452.08 Million | ▲ +219.9% |
| 2019 | 0.14x | CN¥31.66 Million | CN¥232.87 Million | ▼ -71.4% |
| 2018 | 0.48x | CN¥107.88 Million | CN¥226.60 Million | ▼ -23.2% |
| 2017 | 0.62x | CN¥123.88 Million | CN¥199.71 Million | ▲ +13.1% |
| 2016 | 0.55x | CN¥72.91 Million | CN¥132.99 Million | ▼ -50.1% |
| 2015 | 1.10x | CN¥132.82 Million | CN¥120.97 Million | ▲ +52.4% |
| 2014 | 0.72x | CN¥26.58 Million | CN¥36.89 Million | ▲ +90.2% |
| 2013 | 0.38x | CN¥15.15 Million | CN¥40.01 Million | ▼ -44.9% |
| 2012 | 0.69x | CN¥33.86 Million | CN¥49.28 Million | ▲ +1729.9% |
| 2011 | 0.04x | CN¥1.36 Million | CN¥36.28 Million | ▲ +111.2% |
| 2010 | -0.34x | CN¥-15.28 Million | CN¥45.49 Million | ▼ -35.1% |
| 2009 | -0.25x | CN¥-21.24 Million | CN¥85.41 Million | ▼ -151.9% |
| 2008 | 0.48x | CN¥35.59 Million | CN¥74.23 Million | ▲ +405.8% |
| 2007 | 0.09x | CN¥10.46 Million | CN¥110.32 Million | ▼ -80.6% |
| 2006 | 0.49x | CN¥46.05 Million | CN¥94.44 Million | ▲ +214.4% |
| 2005 | 0.16x | CN¥13.01 Million | CN¥83.88 Million | ▼ -67.7% |
| 2004 | 0.48x | CN¥33.77 Million | CN¥70.30 Million | ▲ +120.1% |
| 2003 | 0.22x | CN¥18.17 Million | CN¥83.28 Million | — |